Science & Technology
Machine Learning Phenotypic De Novo Drug Design
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43MH134716-01
Award Ceiling
$1000K
Award Floor
$1000K
Close Date
Jul 31, 2025
Total Funding
$1000K
Expected Awards
1
Posted Date
Aug 15, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R43MH134716-01
Description
SBIR Phase Phase I award: "Machine Learning Phenotypic De Novo Drug Design" awarded to PsychoGenics Inc. in Paramus, New Jersey. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $999,892. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.